Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption

Journal of Cell Biology

Volumn 142, Issue 5, 1998, Pages 1347-1356

  Adebanjo, Olugbenga A ^a   Moonga, Baljit S ^a   Yamate, Tomoo ^b   Sun, Li ^a   Minkin, Cedric ^c   Abe, Etsuko ^b   Zaidi, Mone ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Ca2+ receptor; Ca2+ sensing; IL 6; Osteoporosis; Ryanodine receptor

Indexed keywords

CALCIUM ION; INTERLEUKIN 11; INTERLEUKIN 6; MESSENGER RNA; NICKEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; MOLECULAR INTERACTION; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; BONE RESORPTION; CALCIUM; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN-11; INTERLEUKIN-6; MEMBRANE PROTEINS; NICKEL; OSTEOCLASTS; RATS; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER;

EID: 0032494089     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.142.5.1347     Document Type: Article

References (43)

1. Adebanjo, O.A., M. Pazianas, A. Zaidi, V.S. Shankar, Z.A. Bascal, C.G. Dacke, C.L.-H. Huang, and M. Zaidi. 1994. Quantitative studies on the effect of prostacyclin on freshly isolated rat osteoclasts in culture. J. Endocrinol. 143:375-381.
2. Bellido, T., N. Stahl, T.J. Farruggella, V. Borha, G.D. Yancopoulos, and S.C. Manolagas. 1996. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotropic factor in bone marrow stroma/osteoblastic cells. J. Clin. Invest. 97:431-437.
3. Bellido, T., V.Z. Borba, P. Robertson, and S.C. Manolagas. 1997. Activation of the Janus/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology. 138:3666-3676.
4. Boyde, A., N.N. Ali, and S.J. Jones. 1984. Resorption of dentine by isolated osteoclasts in vitro. Br. Dental J. 156:216-220.
5. Caputo, C. 1981. Nickel substitution for calcium and the timecourse of potassium conductances of single muscle fibres. J. Muscle Res. Cell Motil. 2:167-182.
6. Chambers, T.J., O.A. Reveil, K. Fuller, and N.A. Athanasou. 1984. Resorption of bone by isolated rabbit osteoclasts. J. Cell Sci. 66:383-399.
7. Delvin, R.D., H.G. Bone, and G.D. Roodman. 1996. IL-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J. Clin. Endocrinol. Metab. 81:1893-1897.
8. Dempster, D.W., R.J. Murrills, W.R. Horbert, and T.R. Arnett. 1987. Biological activity of chicken calcitonin: effects on neonatal rat and embryonic chick osteoclasts. J. Bone Miner. Res. 2:443-448.
9. Franchimont, N., S. Rydziel, and E. Canalis. 1997. Interleukin-6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J. Clin. Invest. 100:1797-1803.
10. Greenfield, E.M., M.C. Horowitz, and S.A. Lavish. 1996. Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. J. Biol. Chem. 271:10984-10989.
11. Hilton, D.J., A.A. Hilton, A. Raiceric, S. Rakar, M. Harrison-Smith, N.M. Gough, C.G. Begley, D. Metcalf, N.A. Nicola, and T.A. Wilson. 1994. Cloning of murine IL-11 receptor α chain requirement for gp130 for high affinity binding and signal transduction. EMBO (Eur. Mol. Biol. Organ.) J. 13:4765-4775.
12. Hirata, Y., T. Taga, M. Hibi, N. Nakano, T. Hirano, and T. Kishimoto. 1989. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J. Immunol. 143:2900-2906.
13. Hughes, D.E., R.L. Jilka, S.C. Manolagas, S. Dallas, L.F. Bonewald, G.R. Mundy, and B.F Boyce. 1995. Sex steroids promote osteoclast apoptosis in vitro and in vivo. J. Bone Miner. Res. 10(Suppl.):48.
14. Ishimi, Y., C. Miyaura, C.H. Jin, T. Akatsu, E. Abe, Y. Nakamura, A. Yamaguchi, S. Yoshiki, T. Matsuda, T. Hirano, et al. 1990. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145:3297-3303.
15. Jilka, R.L., G. Hangoc, G. Girasole, G. Passeri, D.C. Williams, J.S. Abrams, B. Boyce, H. Broxmeyer, and S.C. Manolagas. 1992. Increased osteoclast development after estrogen loss: mediation by IL-6. Science. 257:88-91.
16. Kurebayashi, S., Y. Miyashita, T. Hirose, S. Kasayami, S. Akira, and T. Kishimoto. 1997. Characterization of mechanisms of IL-6 gene repression by estrogen receptor. J. Steroid Biochem. Mol. Biol. 60:11-17.
17. Lin, S.-C., T. Yamate, V.Z.C. Borba, G. Girasole, C.A. O'Brien, T. Bellido, E. Abe, and S.C. Manolagas. 1997. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J. Clin. Invest. 100:1980-1990.
18. MacIntyre, I., M. Zaidi, A.S.M.T. Alam, H.K. Datta, B.S. Moonga, P.K. Lidbury, M.R. Hecker, and J.R. Vane. 1991. Osteoclast inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA. 88: 2936-2940.
19. Malgaroli, A., J. Meldolesi, A. Zabonin-Zallone, and A. Teti. 1989. Control of cytosolic free calcium in rat and chicken osteoclasts. J. Biol. Chem. 264: 14342-14347.
20. Manolagas, S.C., and R.L. Jilka. 1995. Bone marrow, cytokines and bone remodelling. N. Engl. J. Med. 332:305-311.
21. May, L.T., R. Neta, L.L. Moldawer, J.S. Kenney, K. Patel, and P.B. Sehgal. 1993. Antibodies chaperone circulating IL-6 "neutralizing" antibodies in vivo. J. Immunol. 151:3225-3236.
22. Moonga, B.S., D.W. Moss, A. Patchell, and M. Zaidi. 1990. Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. J. Physiol. (Lond.). 42:29-45.
23. Moonga, B.S., H.K. Datta, P.J.R. Bevis, C.L.-H. Huang, I. MacIntyre, and M. Zaidi. 1991. Correlates of osteoclast function in the presence of perchlorate ions in the rat. Exp. Physiol. 76:923-933.
24. Narazaki, M., K. Yasukawa, T. Saito, Y. Ohsugi, H. Fukui, Y. Koishihara, G.D. Yancopoulos, T. Taga, and T. Kishimoto. 1993. Soluble form of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 82:1120-1126.
25. Ohsaki, Y., S. Takahashi, T. Scarcez, A. Demulder, T. Nishihara, R. Williams, and G.D. Roodman. 1992. Evidence for an autocrine/paracrine role for IL-6 in bone resorption by giant cells from giant cell tumour of bone. Endocrinology. 131:2229-2234.
26. Roodman, G.D., N. Kurihara, Y. Ohsaki, T. Kukita, D. Hosking, A. Demulder, and F.R Singer. 1992. IL-6 and potential autocrine/paracrine factor in Paget's disease of bone. J. Clin. Invest. 8:46-52.
27. Rosen, L.B., D.D. Ginty, and M.E. Greenberg. 1995. Calcium regulation of gene expression. In Advances in Second Messenger and Phosphoprotein Research Vol. 30. A.R. Means, editor. Raven Press, New York. 225-253.
28. 2+ redistribution and divalent cation modulation. J. Cell. Physiol. 155:120-129.
29. Shen, M., S.T. Dougan, G. McFadden, and M.E. Greenberg. 1988. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol. Cell. Biol. 8:2787-2796.
30. Silver, I.A., R.J. Murrills, and D.J. Etherington. 1988. Microelectrode studies on acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell. Res. 175:266-276.
31. Taga, T., M. Hibi, Y. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp 130. Cell. 58:573-581.
32. Tamura, T., N. Udagawa, N. Takahashi, C. Miyauri, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki, T. Taga, et al. 1993. Soluble IL-6 receptor triggers osteoclast formation by IL-6. Proc. Natl. Acad. Sci. USA. 90: 11924-11928.
33. Vink, A., P. Coulie, G. Warnier, J.C. Renauld, M. Stevens, D. Donckers, and J. Van Snick. 1990. Mouse plasmacytoma growth in vivo: enhancement by interleukin-6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J. Exp. Med. 172:991-1000.
34. Zaidi, M., H.K. Datta, A. Patchell, B.S. Moonga, and I. MacIntyre. 1989. "Calcium-activated" intracellular calcium elevation: a novel mechanism of osteoclast regulation. Biochem. Biophys. Res. Commun. 163:1461-1465.
35. Zaidi, M., I. MacIntyre, and H.K. Datta. 1990. Intracellular calcium in the control of osteoclast function. II. Paradoxical elevation of cytosolic free calcium by verapamil. Biochem. Biophys. Res. Commun. 167:807-812.
36. Zaidi, M., A.S.M.T. Alam, V.S. Shankar, Bax, B.E., B.S. Moonga, P.J.R. Bevis, M. Pazianas, and C.L.-H. Huang. 1992. A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function. Eur. Biophys. J. 21:349-355.
37. 2+ sensing by the osteoclast. Cell Calcium. 14:271-277.
38. Zaidi, M., A.S.M.T. Alam, V.S. Shankar, B.E. Bax, C.M.R. Bax, B.S. Moonga, P.J.R. Bevis, C. Stevens, D.R. Blake, M. Pazianas, and C.L.-H. Huang. 1993b. Cellular biology of bone resorption. Biol. Rev. 68:197-264.
39. 2+ in rat osteoclasts in the presence of thapsigargin. J. Bone Miner. Res. 8:961-967.
40. Zaidi, M., V.S. Shankar, C.L.-H. Huang, B.R. Rifkin, and M. Pazianas. 1994. Molecular mechanisms of calcitonin action. J. Endocrine. 2:459-467.
41. 2+ sensing. J. Clin. Invest. 96:1582-1590.
42. 2+ sensing in rat osteoclasts by femtomolar calcitonin concentrations. Am. J. Physiol. 271:F637-F644.
43. Zipori, D., J. Toledo, and K. Von der Mark. 1985. Phenotypic heterogeneity among stroma cell lines from mouse bone marrow disclosed in their extracellular matrix composition and interaction with normal and leukemic cells. Blood. 66:447-455.